Literature DB >> 15889993

Cancer risk associated with receipt of vaccines contaminated with simian virus 40: epidemiologic research.

Eric A Engels1.   

Abstract

Simian virus (SV)40 was an accidental contaminant of poliovirus vaccines used widely in the USA and other countries in 1955-1962. Exposure to SV40 via contaminated vaccines has led to concern as SV40 causes cancer in laboratory animals. In addition, some laboratories, although not all, have detected SV40 DNA in human tumors including mesothelioma, certain brain tumors, osteosarcoma and non-Hodgkin's lymphoma. This article reviews the data regarding contamination of poliovirus vaccines with SV40 and summarizes the results from epidemiologic studies of vaccine recipients. Long-term follow-up studies have not revealed recipients of SV40-contaminated poliovirus vaccines to be at an increased risk for cancer. Thus, these studies are somewhat reassuring and indicate that either SV40 does not readily infect humans or, following infection, does not cause cancer. Recognizing that the history of SV40 contamination of vaccines highlights an inherent risk of contamination of vaccines with adventitious agents, the Institute of Medicine recently called for the development of a comprehensive US plan to prevent vaccine contamination and respond to potential contamination events when they arise.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15889993     DOI: 10.1586/14760584.4.2.197

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  7 in total

Review 1.  Merkel cell carcinoma: a virus-induced human cancer.

Authors:  Yuan Chang; Patrick S Moore
Journal:  Annu Rev Pathol       Date:  2011-09-13       Impact factor: 23.472

2.  Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus.

Authors:  Joseph G Victoria; Chunlin Wang; Morris S Jones; Crystal Jaing; Kevin McLoughlin; Shea Gardner; Eric L Delwart
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

3.  Can tissue-based immune markers be used for studying the natural history of cancer?

Authors:  Jill Koshiol; Shih-Wen Lin
Journal:  Ann Epidemiol       Date:  2012-04-04       Impact factor: 3.797

4.  The molecular pathogenesis of osteosarcoma: a review.

Authors:  Matthew L Broadhead; Jonathan C M Clark; Damian E Myers; Crispin R Dass; Peter F M Choong
Journal:  Sarcoma       Date:  2011-04-13

5.  A multi-center, qualitative assessment of pediatrician and maternal perspectives on rotavirus vaccines and the detection of Porcine circovirus.

Authors:  Daniel C Payne; Sharon Humiston; Douglas Opel; Allison Kennedy; Mary Wikswo; Kimberly Downing; Eileen J Klein; Ana Kobayashi; David Locke; Christina Albertin; Claudia Chesley; Mary A Staat
Journal:  BMC Pediatr       Date:  2011-09-26       Impact factor: 2.125

Review 6.  Molecular genetics of ependymoma.

Authors:  Yuan Yao; Stephen C Mack; Michael D Taylor
Journal:  Chin J Cancer       Date:  2011-10

7.  Serologic response to porcine circovirus type 1 (PCV1) in infants vaccinated with the human rotavirus vaccine, Rotarix™: A retrospective laboratory analysis.

Authors:  Htay Htay Han; Naveen Karkada; Girish Jayadeva; Gary Dubin
Journal:  Hum Vaccin Immunother       Date:  2017-01-02       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.